The Immune System

   The immune system is a complex network of cells, tissues, and organs that work together to defend the body against harmful invaders, such as pathogens (e.g., bacteria, viruses, fungi), toxins, and abnormal cells (e.g., cancer cells). It consists of two main branches: the innate immune system and the adaptive immune system. The innate immune system provides immediate, nonspecific defense mechanisms, including physical barriers (e.g., skin, mucous membranes), chemical barriers (e.g., stomach acid, antimicrobial proteins), and innate immune cells (e.g., neutrophils, macrophages, natural killer cells). The adaptive immune system, on the other hand, mounts a highly specific response tailored to each pathogen encountered. It involves specialized immune cells (e.g., T cells, B cells) and the production of antibodies, which target specific antigens present on pathogens. Through processes like phagocytosis, cytokine signaling, and antibody-mediated responses, the immune system identifies and eliminates foreign invaders while maintaining tolerance to self-tissues.

• Autoimmune Diseases: Conditions in which the immune system mistakenly attacks healthy tissues, mistaking them for foreign invaders. Examples include rheumatoid      arthritis, systemic lupus erythematosus (SLE), multiple sclerosis, type 1 diabetes, and celiac disease.
• Immunodeficiency Disorders: Conditions characterized by impaired immune function, resulting in increased susceptibility to infections. Primary immunodeficiencies are usually genetic, such as severe combined immunodeficiency (SCID), while      secondary immunodeficiencies can result from diseases (e.g., HIV/AIDS),      medications, or treatments (e.g., chemotherapy).
• Allergic Disorders: Conditions involving exaggerated immune responses to harmless substances (allergens), leading to symptoms such as allergic rhinitis (hay fever),      asthma, atopic dermatitis (eczema), and food allergies.
• Immune-mediated Inflammatory Disorders: Conditions characterized by chronic inflammation driven by immune system dysregulation, such as inflammatory bowel diseases (Crohn's disease, ulcerative colitis) and psoriasis.

• Inflammation: Insulin resistance and metabolic syndrome are associated with chronic      low-grade inflammation, which can contribute to the pathogenesis of autoimmune diseases and inflammatory disorders.
• Immune Dysregulation: Dysregulated insulin signaling pathways may impact immune cell function and cytokine production, potentially leading to immune system dysfunction and autoimmune responses.
• Increased Infection Risk  Insulin resistance and metabolic abnormalities can impair immune responses to infections, leading to increased susceptibility to microbial pathogens and exacerbation of immunodeficiency disorders.
• Allergic Responses: Insulin resistance and metabolic syndrome components such as obesity and dyslipidemia are associated with increased allergic sensitization and      susceptibility to allergic disorders.
• Altered Gut Microbiota:      Metabolic abnormalities may affect the composition and function of the gut microbiota, influencing immune system development, tolerance, and inflammatory responses, contributing to immune-mediated disorders like      inflammatory bowel diseases.

 Promotes chronic low-grade inflammation, which can impair immune function and increase susceptibility to infections. 

 Impairs immune response, leading to frequent infections, delayed wound healing, and an increased risk of complications

1. Srivastava, S. et al. (2023) ‘Immune Modulatory Effects of Ketogenic Diet in Different Disease Conditions’, Immuno, 3(1), pp. 1–15. Available at: https://doi.org/10.3390/immuno3010001.
2. Hirschberger  S, Strauß G, Effinger D, et al. Very-low-carbohydrate diet enhances  human T-cell immunity through immunometabolic reprogramming. EMBO Molecular Medicine. Published online June 21, 2021:e14323. doi:10.15252/emmm.202114323
3. Breukelman  GJ, Shaw BS, Basson AK, Djarova TG, Millard L, Shaw I. Immune Function  Response Following a Low-carbohydrate, High-fat Diet (LCHFD) in Patients  with type 2 Diabetes. Asian Journal of Sports Medicine. Published  December 30, 2025. doi:10.5812/asjsm.106582. 
4. Lorenzo, P.M. et al. (2022) ‘Immunomodulatory effect of a very-low-calorie ketogenic diet  compared with bariatric surgery and a low-calorie diet in patients with  excessive body weight’, Clinical Nutrition, 0(0). doi:10.1016/j.clnu.2022.05.007.
5. Stubbs  BJ, Koutnik AP, Goldberg EL, et al. Investigating Ketone Bodies as  Immunometabolic Countermeasures against Respiratory Viral Infections. Med (N Y). Published online July 15, 2020. doi:10.1016/j.medj.2020.06.008
6. Watanabe, M. et al. (2022) ‘Rapid Weight Loss, Central Obesity Improvement and Blood  Glucose Reduction Are Associated with a Stronger Adaptive Immune  Response Following COVID-19 mRNA Vaccine’, Vaccines, 10(1), p. 79. doi:10.3390/vaccines10010079.
7. Wood TR, Jóhannsson GF. Metabolic health and lifestyle medicine should be a cornerstone of future pandemic preparedness. Lifestyle Medicine. 2020;n/a(n/a):e2. doi:10.1002/lim2.2 
8. Gangitano E, Tozzi R, Gandini O, et al. Ketogenic Diet as a Preventive and Supportive Care for COVID-19 Patients. Nutrients. 2021;13(3):1004. doi:10.3390/nu13031004
9. Barrea, L. et al. (2022) ‘From the Ketogenic Diet to the Mediterranean Diet: The  Potential Dietary Therapy in Patients with Obesity after CoVID-19  Infection (Post CoVID Syndrome)’, Current Obesity Reports [Preprint]. doi:10.1007/s13679-022-00475-z.
10. Wilhelm C, Surendar J, Karagiannis F. Enemy or ally? Fasting as an essential regulator of immune responses. Trends Immunol. Published online April 14, 2021. doi:10.1016/j.it.2021.03.007 
11. Ealey KN, Phillips J, Sung H-K. COVID-19 and obesity: Fighting two pandemics with intermittent fasting. Trends in Endocrinology & Metabolism. Published online June 25, 2021. doi:10.1016/j.tem.2021.06.004 PDF
12. Bhatti,  S.I. and Mindikoglu, A.L. (2021) ‘The impact of dawn to sunset fasting  on immune system and its clinical significance in Covid-19 pandemic’, Metabolism Open, p. 100162. doi:10.1016/j.metop.2021.100162.
13. Nassar MF, El Gendy YGA, Hamza MT, Mohamed MN, Radwan N. The Effect of Ketogenic Diet on Neutrophil Count. QJM: An International Journal of Medicine. 2021;114(Supplement_1). doi:10.1093/qjmed/hcab113.041  ABSTRACT
14. Goldberg  EL, Molony RD, Kudo E, et al. Ketogenic diet activates protective γδ T  cell responses against influenza virus infection. Science Immunology. 2019;4(41). doi:10.1126/sciimmunol.aav2026 (pre-clinical)
15. Ryu S, Shchukina I, Youm Y-H, et al. Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice. Elife. 2021;10:e66522. doi:10.7554/eLife.66522 PDF (pre-clinical)

 Hashimoto's disease, also known as Hashimoto's thyroiditis or chronic lymphocytic thyroiditis, is an autoimmune condition that affects the thyroid gland. In Hashimoto's disease, the immune system mistakenly attacks the thyroid gland, leading to inflammation and damage over time. This can result in hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormones.

The exact cause of Hashimoto's disease is not fully understood, but it is believed to involve a combination of genetic predisposition and environmental factors, such as viral infections and hormonal imbalances. Women are more commonly affected by Hashimoto's disease than men, and it often develops during middle age.

Key features of Hashimoto's disease include:

1. Thyroid Inflammation: Hashimoto's disease is characterized by chronic inflammation of the thyroid gland, leading to the destruction of thyroid tissue. This can cause the thyroid gland to become enlarged (a condition known as a goiter) and may result in pain or discomfort in the neck.
2. Hypothyroidism: As Hashimoto's disease progresses, it can lead to decreased thyroid function and hypothyroidism. Hypothyroidism occurs when the thyroid gland does not produce enough thyroid hormones, which are essential for regulating metabolism, energy production, and various bodily functions. Symptoms of hypothyroidism may include fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, and depression.
3. Autoimmune Features: Hashimoto's disease is an autoimmune condition, meaning it is caused by the immune system attacking the body's own tissues. It is often associated with the presence of autoantibodies, such as thyroid peroxidase antibodies (TPO antibodies) and thyroglobulin antibodies (TG antibodies), which can be detected through blood tests.
4. Risk of Thyroid Cancer: In some cases, Hashimoto's disease may increase the risk of developing thyroid cancer, particularly in individuals with long-standing inflammation and nodular changes in the thyroid gland.

Treatment for Hashimoto's disease typically involves medications to replace thyroid hormones (levothyroxine) and restore normal thyroid function. The goal of treatment is to alleviate symptoms of hypothyroidism, prevent complications, and maintain thyroid hormone levels within a normal range. In some cases, additional treatment may be necessary to manage goiter or other complications associated with Hashimoto's disease.

 Recent research has explored potential links between Hashimoto's  disease, an autoimmune thyroid condition, and metabolic disorders like  hyperinsulinemia, insulin resistance, and metabolic syndrome. While the  exact mechanisms remain unclear, it's hypothesized that metabolic  factors could influence thyroid function and autoimmune processes.  Elevated insulin levels, as seen in hyperinsulinemia, may promote  inflammation and autoimmune reactions, potentially exacerbating thyroid  inflammation. Insulin resistance, common in metabolic syndrome, could  contribute to chronic low-grade inflammation and immune dysregulation,  affecting Hashimoto's disease progression. Additionally, metabolic  syndrome's cluster of conditions may impact immune response and thyroid  inflammation. However, further research is needed to understand these  relationships fully. It's crucial for individuals with Hashimoto's  disease to manage any coexisting metabolic conditions, as they may  affect overall health and possibly the course of autoimmune thyroid  disease. Healthcare providers may consider screening for metabolic  disorders in those with Hashimoto's disease and vice versa to optimize  management and reduce complications. 

  Krysiak R, Szkróbka W, Okopień B.  The Effect of Gluten-Free Diet on Thyroid Autoimmunity in Drug-Naïve  Women with Hashimoto’s Thyroiditis: A Pilot Study. Exp Clin Endocrinol  Diabetes. 2019;127(07):417-422. doi:10.1055/a-0653-7108

Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination (damage to the protective covering of nerve fibers), and neurodegeneration in the central nervous system (brain and spinal cord). While the exact cause of MS is not fully understood, hyperinsulinemia, characterized by elevated levels of insulin in the blood, may influence MS through several mechanisms. Insulin resistance, a hallmark of hyperinsulinemia and metabolic syndrome, is associated with chronic low-grade inflammation, which can contribute to immune dysregulation and promote autoimmune responses. Additionally, hyperinsulinemia may exacerbate neuroinflammation and oxidative stress, further damaging nerve cells and worsening MS symptoms. Furthermore, insulin resistance can impair nerve cell repair mechanisms and myelin regeneration, hindering the recovery process in individuals with MS. Therefore, managing hyperinsulinemia through lifestyle modifications, insulin-sensitizing medications, and appropriate medical interventions may help reduce inflammation and slow disease progression in individuals with MS. Additionally, individuals with MS should work closely with healthcare professionals to optimize treatment, manage symptoms, and improve quality of life.

 Patients with multiple sclerosis frequently report sleep complaints.

• •Although ketogenic diet is safe and tolerable in patients with multiple sclerosis, data on its effects on sleep are lacking.
• •After ketogenic diet, patients reported lower prevalence of poor sleep quality and daytime somnolence.
• •Ketogenic diet improved psychological status and quality of life as well.
• •Ketogenic diet positively impacted on psychological status and QoL of MS patients, mainly through improving sleep quality.

 Sepsis primarily affects the immune system and can have widespread  effects on various organ systems throughout the body. However, it is  often classified within the context of the cardiovascular system because  of its significant impact on blood circulation and blood pressure  regulation. Sepsis involves a dysregulated immune response to an  infection, leading to systemic inflammation, vascular leakage, and  impaired tissue perfusion, which can ultimately result in multiple organ  dysfunction syndrome (MODS) and septic shock. Therefore, while sepsis  affects multiple organ systems, it is often discussed and managed in the  context of its cardiovascular manifestations. 

Insulin resistance, hyperinsulinemia, and metabolic syndrome can influence the body's response to sepsis through several interconnected mechanisms:

Impaired immune function: Insulin resistance and metabolic syndrome are associated with chronic low-grade inflammation and dysregulated immune responses. This chronic inflammation can weaken the immune system's ability to mount an effective response to pathogens, making individuals more susceptible to infections like sepsis. Additionally, hyperinsulinemia can directly suppress immune function, impairing the body's ability to fight off infections.

Dysregulated glucose metabolism: Insulin resistance and metabolic syndrome often involve dysregulated glucose metabolism, resulting in elevated blood glucose levels. High blood glucose levels can provide a favorable environment for bacterial growth and proliferation, exacerbating infections and potentially worsening the severity of sepsis.

Endothelial dysfunction: Insulin resistance and metabolic syndrome are characterized by endothelial dysfunction, which refers to impaired function of the cells lining the blood vessels. Endothelial dysfunction can lead to increased vascular permeability and impaired microcirculation, which are hallmark features of sepsis. This dysfunction can exacerbate tissue damage and organ dysfunction during sepsis.

Prothrombotic state: Insulin resistance and metabolic syndrome are associated with a prothrombotic state characterized by increased blood clotting and impaired fibrinolysis. In sepsis, this prothrombotic state can lead to microvascular thrombosis, impairing blood flow to vital organs and contributing to organ dysfunction.

Altered stress response: Insulin resistance and metabolic syndrome can disrupt the body's stress response mechanisms, including the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system. These alterations may impair the body's ability to mount an appropriate response to the stress of sepsis, potentially exacerbating its severity and increasing the risk of complications.

Overall, insulin resistance, hyperinsulinemia, and metabolic syndrome can exacerbate the immune dysregulation, metabolic dysfunction, endothelial dysfunction, prothrombotic state, and altered stress response associated with sepsis. Therefore, individuals with these conditions may be at increased risk of developing sepsis and experiencing more severe outcomes if they do develop the condition.

This condition is on the list because it happened to me twice. Both  shortly before T2 diagnosis , both very frightening incidents and neither gave rise to testing for T2 Diabetes.  

  Systemic lupus erythematosus (SLE) is a chronic autoimmune disease  characterized by inflammation that can affect various organs and tissues  throughout the body. 

 Some of the systems commonly affected by lupus include:

1. Skin: Lupus can cause a variety of skin manifestations, such as a butterfly-shaped rash across the cheeks and nose (malar rash), discoid lesions, photosensitivity (increased sensitivity to sunlight), and ulcers.
2. Joints: Lupus can cause arthritis, leading to pain, swelling, and stiffness in the joints. Arthritis associated with lupus often affects multiple joints and tends to be migratory in nature.
3. Kidneys: Lupus nephritis is a serious complication of lupus in which the immune system attacks the kidneys, leading to inflammation and damage. It can result in proteinuria (excessive protein in the urine), hematuria (blood in the urine), hypertension (high blood pressure), and impaired kidney function.
4. Cardiovascular System: Lupus can affect the heart and blood vessels, leading to inflammation of the pericardium (lining around the heart), myocarditis (inflammation of the heart muscle), and vasculitis (inflammation of blood vessels). It can increase the risk of cardiovascular disease, including heart attacks and strokes.
5. Lungs: Lupus can cause inflammation of the lungs (pleuritis), resulting in chest pain and difficulty breathing. It can also lead to inflammation of the lining around the lungs (pleural effusion) and pulmonary hypertension (high blood pressure in the arteries of the lungs).
6. Central Nervous System: Lupus can affect the central nervous system, leading to symptoms such as headaches, cognitive dysfunction (brain fog), seizures, mood changes, and psychosis.
7. Blood: Lupus can affect blood cells, leading to anemia (low red blood cell count), leukopenia (low white blood cell count), and thrombocytopenia (low platelet count). It can also increase the risk of blood clots (thrombosis).

While the exact cause of SLE is not fully  understood, hyperinsulinemia, marked by elevated levels of insulin in  the blood, may influence SLE through several mechanisms. Insulin  resistance, a hallmark of hyperinsulinemia and metabolic syndrome, is  associated with chronic low-grade inflammation, which can contribute to  immune dysregulation and promote autoimmune responses. Additionally,  hyperinsulinemia may exacerbate inflammation and oxidative stress,  further damaging tissues and worsening SLE symptoms. Furthermore,  insulin resistance can impair immune cell function and increase  susceptibility to infections, which can trigger or exacerbate SLE  flares. Therefore, managing hyperinsulinemia through lifestyle  modifications, insulin-sensitizing medications, and appropriate medical  interventions may help reduce inflammation and improve outcomes in  individuals with SLE. Additionally, individuals with SLE should work  closely with healthcare professionals to optimize treatment, manage  symptoms, and minimize complications associated with the disease.  

1. Esposito  T, Lobaccaro JM, Esposito MG, et al. Effects of low-carbohydrate diet  therapy in overweight subjects with autoimmune thyroiditis: possible  synergism with ChREBP. Drug Des Devel Ther. 2016;10:2939-2946. doi:10.2147/DDDT.S106440
2. Choi  IY, Lee C, Longo VD. Nutrition and fasting mimicking diets in the  prevention and treatment of autoimmune diseases and immunosenescence. Molecular and Cellular Endocrinology. 2017;455:4-12. doi:10.1016/j.mce.2017.01.042 PDF
3. Miyake  CNH, Gualano B, Dantas WS, et al. Increased Insulin Resistance and  Glucagon Levels in Mild/Inactive Systemic Lupus Erythematosus Patients  Despite Normal Glucose Tolerance. Arthritis Care & Research.  2018;70(1):114-124. doi:10.1002/acr.23237
4. Davies  RJ, Lomer MCE, Yeo SI, Avloniti K, Sangle SR, D’Cruz DP. Weight loss  and improvements in fatigue in systemic lupus erythematosus: a  controlled trial of a low glycaemic index diet versus a calorie  restricted diet in patients treated with corticosteroids. Lupus.  2012;21(6):649-655. doi:10.1177/0961203312436854 ABSTRACT
5. Krysiak  R, Szkróbka W, Okopień B. The Effect of Gluten-Free Diet on Thyroid  Autoimmunity in Drug-Naïve Women with Hashimoto’s Thyroiditis: A Pilot  Study. Exp Clin Endocrinol Diabetes. 2019;127(07):417-422. doi:10.1055/a-0653-7108
6. Jiang  Y, Jarr K, Layton C, et al. Therapeutic Implications of Diet in  Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory  Diseases. Nutrients. 2021;13(3). doi:10.3390/nu13030890
7. Ciaffi, J. et al. (2021) ‘The Effect of Ketogenic Diet on Inflammatory Arthritis and  Cardiovascular Health in Rheumatic Conditions: A Mini Review’, Frontiers in Medicine, 8. doi: 10.3389/fmed.2021.792846